Quick Search / Select a Section

About Us

The Surrey Cancer Research Institute is a Clinical Academic Group (CAG) within Surrey Health Partners (SHP) working in partnership with Royal Surrey County Hospital NHS FT, St Luke's Cancer Centre, the St Luke’s Cancer Alliance, University of Surrey, Ashford and St Peter’s NHS FT and other organisations to deliver world class research into cancer treatment and service delivery.

Primary objectives for the Surrey Cancer Research Institute include:

Our People

Prof. Hardev Pandha FSB FRCP FRACP PhD

Director, Surrey Cancer Research Institute, Prof of Medical Oncology University of Surrey. Consultant in Medical Oncology, St Lukes Cancer Centre, Guildford.

Hardev Pandha is Professor of Medical Oncology and a Consultant Medical Oncologist at St Lukes Cancer Centre. He leads a joint laboratory research and experimental clinical trials program. His key areas of interest in immunotherapy and gene therapy for cancer. He specialises in the treatment of urological cancers.

Prof. Andrew Nisbet

Director, Surrey Cancer Research Institute, Director of the University of Surrey Cancer Research. http://www.surrey.ac.uk/people/andrew-nisbet   http://www.surreycancer.org.uk/radiation-oncology.htm

Wendy Hobby

Support Assistant, Wendy is a Research Support Assistant who for the past 7 years has been providing admin support to Professor Pandha and the Oncology team at the University of Surrey and is now doing the same within her role supporting the Surrey Cancer Research Institute.  Having started her career within government veterinary laboratories as an assistant scientific officer she progressed to become a highly experienced PA, she has spent the last 35 years working within the Medical Sector.

Dr Kate Relph
Research Support, Kate studied Biochemistry at the University of Bristol and spent a year at Roche Pharmaceuticals as part of her industrial sandwich placement. Following this she went on to study for a PhD at the University of Oxford. After this she went on to do a postdoctoral fellowship at the Ludwig Institute for Cancer Research where she developed retrovial vectors to immortalise primary breast cells within the laboratory of Professor Parmjit Jat.  Kate began working for Professor Pandha at St George’s, University of London as a science writer. When Professor Pandha gained his chair at the University of Surrey Kate moved with him to help set up his group.

Our Strategy

A Unified approach to cancer research.

The Surrey Cancer Research Institute is a virtual institute launched alongside the recent Surrey Health Partners (SHP) initiative.

SHP is a strong collaborative framework to facilitate research, teaching, applications for grant funding with the overall aim of improving patient outcomes. The Surrey Cancer Research Institute's strategy is to unify cancer research groups within the Surrey/Sussex/Kent cancer networks.

Experience, diversity and sharing.

The Surrey Cancer Research Institute website will encompass multidisciplinary research as ‘divisions’- its modular form will encourage new groups to become members. Each division will be led by an experienced researcher. The clear visibility of research programs within the Surrey Cancer Research Institute will allow easier collaboration, grant application and an efficient sharing of resources. The first phase of the Surrey Cancer Research Institute's strategy implementation will also see the development of a monthly keynote seminar series, reflecting the various specialist areas. Work will begin on generating key assets and core technologies which will be shared by Surrey Cancer Research Institute members and outside collaborators. These include creation of new tissue biobanks and generation of tissue microarrays. The establishment of the Surrey Cancer Research Institute will allow member research groups, affiliated Trusts and Universities and St Lukes Cancer Centre to realise their potential and gain national and international profile.

Our Partners